Comparison of escitalopram vs. citalopram and venlafaxine in the treatment of major depression in Spain: clinical and economic consequences

@article{SicrasMainar2010ComparisonOE,
  title={Comparison of escitalopram vs. citalopram and venlafaxine in the treatment of major depression in Spain: clinical and economic consequences},
  author={A. Sicras-Mainar and R. Navarro-Artieda and M. Blanca-tamayo and Victoria Gimeno-de la Fuente and Jordi Salvatella-Pasant},
  journal={Current Medical Research and Opinion},
  year={2010},
  volume={26},
  pages={2757 - 2764}
}
  • A. Sicras-Mainar, R. Navarro-Artieda, +2 authors Jordi Salvatella-Pasant
  • Published 2010
  • Medicine
  • Current Medical Research and Opinion
  • Abstract Study objective: Population based study to determine the clinical consequences and economic impact of using escitalopram (ESC) vs. citalopram (CIT) and venlafaxine (VEN) in patients who initiate treatment for a new episode of major depression (MD) in real life conditions of outpatient practice. Methods: Observational, multicenter, retrospective study conducted using computerized medical records (administrative databases) of patients treated in six primary care centers and two hospitals… CONTINUE READING
    6 Citations

    References

    SHOWING 1-10 OF 38 REFERENCES
    Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder
    • 32
    Escitalopram versus other antidepressive agents for depression.
    • 166
    The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression
    • 105